Description
The TaqPath COVID-19, Flu A, Flu B Combo Kit includes the assays and controls for a multiplex real-time RT-PCR test for the qualitative detection and differentiation of RNA from SARS-CoV-2, influenza A, and influenza B viruses in nasopharyngeal and anterior nasal swabs from individuals suspected of COVID-19 by their healthcare provider.
Features:
- Single test for SARS-CoV-2, influenza A, and influenza B — detect and differentiate between disease states with similar clinical symptoms and get information needed to help monitor spread of COVID-19 and flu
-
Affordable and scalable— add to your existing COVID-19 testing menu and infrastructure to expand your respiratory sample testing while maintaining low operational costs and workflow simplicity
-
Multitarget assay design— helps compensate for emerging SARS-CoV-2 variants and mutations to help provide confidence in results
-
Complete solution for clinical labs— Applied Biosystems Pathogen Interpretive Software automatically converts genetic analysis data into a readable report, helping reduce risk of user interpretation error
-
Emergency Use Authorized